Cardiotoxin molecular toxicology modeling

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01) C12Q 1/02 (2006.01) G01N 33/53 (2006.01) G06F 19/00 (2006.01)

Patent

CA 2452897

The present invention is based on the elucidation of the global changes in gene expression and the identification of toxicity markers in tissues or cells exposed to a known cardiotoxin. The genes may be used as toxicity markers in drug screening and toxicity assays. The invention includes a database of genes characterized by toxin-induced differential expression that is designed for use with microarrays and other solid-phase probes.

La présente invention repose sur l'élucidation des modifications globales de l'expression génique et sur l'identification de marqueurs de toxicité dans des tissus ou des cellules exposés à une cardiotoxine connue. Les gènes peuvent être utilisés comme marqueurs de toxicité dans le criblage de médicaments et dans des analyses de toxicité. L'invention comprend une base de données de gènes caractérisés par une expression différentielle induite par la toxine, qui est conçue pour être utilisée avec des biopuces ou d'autres sondes à phase solide.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cardiotoxin molecular toxicology modeling does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cardiotoxin molecular toxicology modeling, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiotoxin molecular toxicology modeling will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1846511

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.